Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-3.48M.
ENTERPRISE VALUE (EV)
$-3.48M
bioAffinity Technologies, Inc.
Market Cap
$2.55M
Enterprise Value (EV)
$-3.48M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | $2.55M | $-3.48M |
| FibroBiologics, Inc. Common Stock (FBLG)vs › | $2.54M | $483126.00 |
| Jaguar Health, Inc. (JAGX)vs › | $2.56M | $12.62M |
| Nuwellis, Inc. (NUWE)vs › | $2.61M | N/A |
| Moleculin Biotech, Inc. (MBRX)vs › | $2.45M | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.67M | N/A |
| Onconetix, Inc. (ONCO)vs › | $2.38M | N/A |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH)vs › | $2.37M | $2.48M |
| Creative Medical Technology Holdings, Inc. (CELZ)vs › | $2.31M | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.15M | N/A |
Market Cap
$2.55M
Total Debt
$425184.00
Cash
$6.45M
Enterprise Value
$-3.48M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
